Open AccessTransient abnormal myelopoiesis in pediatrics with trisomy 21
Author(s) -
Taee Nadereh,
FarajiGoodarzi Mojgan,
Safdari Mohammad,
Bajelan Amir
Publication year - 2021
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.3589
Subject(s) - medicine , myelopoiesis , trisomy , pediatrics , down syndrome , intensive care medicine , haematopoiesis , genetics , stem cell , psychiatry , biology
Transient abnormal myelopoiesis is common among Down syndrome patients. Although no therapeutic measures are required, close monitoring of comorbidities such as gastrointestinal bleeding is required. Long‐term follow‐up is promising for a healthy future and reduced requirement of unnecessary therapeutic measures including chemotherapy and remission of the pathology.